Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy

Abstract Data from patients with suspicious lesions on multiparametric magnetic resonance (mpMRI) and a diagnosis of clinically significant prostate cancer (csPCa) who underwent radical prostatectomy (RP) were collected. The aim was to compare csPCa sites identified through whole-mount pathological...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Pacini, Alessandro Zucchi, Riccardo Morganti, Filippo Dazzi, Antonio Luigi Pastore, Fabio Maria Valenzi, Andrea Fuschi, Yazan al Salhi, Gianluca Giannarini, Vincenzo Ficarra, Alchiede Simonato, Petar Antonov, Pinuccia Faviana, Riccardo Bartoletti
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88463-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862465889304576
author Matteo Pacini
Alessandro Zucchi
Riccardo Morganti
Filippo Dazzi
Antonio Luigi Pastore
Fabio Maria Valenzi
Andrea Fuschi
Yazan al Salhi
Gianluca Giannarini
Vincenzo Ficarra
Alchiede Simonato
Petar Antonov
Pinuccia Faviana
Riccardo Bartoletti
author_facet Matteo Pacini
Alessandro Zucchi
Riccardo Morganti
Filippo Dazzi
Antonio Luigi Pastore
Fabio Maria Valenzi
Andrea Fuschi
Yazan al Salhi
Gianluca Giannarini
Vincenzo Ficarra
Alchiede Simonato
Petar Antonov
Pinuccia Faviana
Riccardo Bartoletti
author_sort Matteo Pacini
collection DOAJ
description Abstract Data from patients with suspicious lesions on multiparametric magnetic resonance (mpMRI) and a diagnosis of clinically significant prostate cancer (csPCa) who underwent radical prostatectomy (RP) were collected. The aim was to compare csPCa sites identified through whole-mount pathological analysis (WMA) after RP with PI-RADS ≥ 3 lesions identified on mpMRI, and with csPCa foci detected through targeted-biopsy (TB) or combined targeted + systematic biopsy (TSB). A paired Student’s t-test and Pearson correlation analysis were performed to evaluate the agreement between these diagnostic methods. A total of 106 patients were included in the TSB group and 95 in the TB group. The correlation between mpMRI, PB, and WMA was moderate and comparable in both groups. No correlation between PB and WMA was found in the TB group for PI-RADS3 lesions, while a moderate-strong correlation was observed when comparing mpMRI, PB, and WMA for PI-RADS > 3 lesions. About 50% of csPCa sites remained undetected by mpMRI. TSB was able to identify 16.5% more csPCa sites than TB. mpMRI is an accurate method in the diagnosis of PCa, especially for PI-RADS > 3 lesions, although some csPCa sites remained undetected. The use of TSB improved the location agreement between PB and WMA, increasing detection rates up to 79%.
format Article
id doaj-art-2c9701c1bc484db7af39f86d2d72897d
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2c9701c1bc484db7af39f86d2d72897d2025-02-09T12:29:44ZengNature PortfolioScientific Reports2045-23222025-02-011511910.1038/s41598-025-88463-wCorrelation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategyMatteo Pacini0Alessandro Zucchi1Riccardo Morganti2Filippo Dazzi3Antonio Luigi Pastore4Fabio Maria Valenzi5Andrea Fuschi6Yazan al Salhi7Gianluca Giannarini8Vincenzo Ficarra9Alchiede Simonato10Petar Antonov11Pinuccia Faviana12Riccardo Bartoletti13Department of Translational Research and New Technologies in Medicine and Surgery, University of PisaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of PisaAzienda Ospedaliero Universitaria Pisana, UO statisticaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of PisaDepartment of Medical and Surgical Science and Biotechnology, La Sapienza UniversityDepartment of Medical and Surgical Science and Biotechnology, La Sapienza UniversityDepartment of Medical and Surgical Science and Biotechnology, La Sapienza UniversityDepartment of Medical and Surgical Science and Biotechnology, La Sapienza UniversityUrology Unit, Santa Maria della Misericordia University HospitalDepartment of Clinical and Experimental Medicinel, University of MessinaDepartment of Precision Medicine in Medical, Surgical and Critical Area, University of PalermoDepartment of Urology and General Medicine, Medical University of PlovdivDepartment of Department of Surgery, Medical, Molecular, and Critical Area, University of PisaDepartment of Translational Research and New Technologies in Medicine and Surgery, University of PisaAbstract Data from patients with suspicious lesions on multiparametric magnetic resonance (mpMRI) and a diagnosis of clinically significant prostate cancer (csPCa) who underwent radical prostatectomy (RP) were collected. The aim was to compare csPCa sites identified through whole-mount pathological analysis (WMA) after RP with PI-RADS ≥ 3 lesions identified on mpMRI, and with csPCa foci detected through targeted-biopsy (TB) or combined targeted + systematic biopsy (TSB). A paired Student’s t-test and Pearson correlation analysis were performed to evaluate the agreement between these diagnostic methods. A total of 106 patients were included in the TSB group and 95 in the TB group. The correlation between mpMRI, PB, and WMA was moderate and comparable in both groups. No correlation between PB and WMA was found in the TB group for PI-RADS3 lesions, while a moderate-strong correlation was observed when comparing mpMRI, PB, and WMA for PI-RADS > 3 lesions. About 50% of csPCa sites remained undetected by mpMRI. TSB was able to identify 16.5% more csPCa sites than TB. mpMRI is an accurate method in the diagnosis of PCa, especially for PI-RADS > 3 lesions, although some csPCa sites remained undetected. The use of TSB improved the location agreement between PB and WMA, increasing detection rates up to 79%.https://doi.org/10.1038/s41598-025-88463-wProstate cancer diagnosisMultiparametric magnetic resonanceTargeted fusion prostate biopsySystematic prostate biopsyWhole mount pathological analysis
spellingShingle Matteo Pacini
Alessandro Zucchi
Riccardo Morganti
Filippo Dazzi
Antonio Luigi Pastore
Fabio Maria Valenzi
Andrea Fuschi
Yazan al Salhi
Gianluca Giannarini
Vincenzo Ficarra
Alchiede Simonato
Petar Antonov
Pinuccia Faviana
Riccardo Bartoletti
Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
Scientific Reports
Prostate cancer diagnosis
Multiparametric magnetic resonance
Targeted fusion prostate biopsy
Systematic prostate biopsy
Whole mount pathological analysis
title Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
title_full Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
title_fullStr Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
title_full_unstemmed Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
title_short Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
title_sort correlation of clinically significant prostate cancer sites across multiparametric mri prostate biopsy and whole mount pathology for optimal prostate biopsy strategy
topic Prostate cancer diagnosis
Multiparametric magnetic resonance
Targeted fusion prostate biopsy
Systematic prostate biopsy
Whole mount pathological analysis
url https://doi.org/10.1038/s41598-025-88463-w
work_keys_str_mv AT matteopacini correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT alessandrozucchi correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT riccardomorganti correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT filippodazzi correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT antonioluigipastore correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT fabiomariavalenzi correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT andreafuschi correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT yazanalsalhi correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT gianlucagiannarini correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT vincenzoficarra correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT alchiedesimonato correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT petarantonov correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT pinucciafaviana correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy
AT riccardobartoletti correlationofclinicallysignificantprostatecancersitesacrossmultiparametricmriprostatebiopsyandwholemountpathologyforoptimalprostatebiopsystrategy